Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Silicate vs Calcium Hydroxide in Periapical Lesions
NCT06307678Completed
- Sponsor
- Atatürk University
- Start
- Jul 2023
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Randomised trial of TheraCal in Periapical Abscess and apical periodontitis (AP) (2 arms), sponsored by Atatürk University. Primary endpoints: Receptor Activator of Nuclear Factor Kappa-B Ligand / Osteoprotegerin Ratio at 1 week, Prostaglandin E2 at 1 week and 2 more. Started Jul 2023; status: completed.
02
Drugs
TheraCal
03
Conditions
Periapical Abscessapical periodontitis (AP)
Beyond the preview
Go deeper on NCT06307678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06307678.